My watch list
my.bionity.com  
Login  

8,240 Current news from the industry pharma

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

image description
BASF and Biomillenia join forces in microbiome research

08-Oct-2019

BASF and Biomillenia announced the signing of a microbiome discovery agreement. The collaboration aims to identify novel dermocosmetic active ingredients involved in promoting skin health. The French company Biomillenia will contribute its unique microbiome-on-a-chip technology that has the ...

more

Evotec reaches milestone in integrated drug discovery and development partnership with Aeovian

07-Oct-2019

Evotec SE announced that the Company has reached a milestone in a drug discovery and development partnership with the biopharmaceutical company Aeovian Pharmaceuticals, Inc. Aeovian and Evotec entered into a drug discovery partnership in 2017 to discover and develop new and highly selective ...

more

Chemicals for pharmaceuticals could be made cheaper and greener by new catalysts

04-Oct-2019

High value chemicals used to make pharmaceuticals could be made much cheaper and quicker thanks to a series of new catalysts made by scientists at the University of Warwick in collaboration with GoldenKeys High-Tech Co., Ltd. in China. The process of making high-value chemicals for uses such as ...

more

Scientists come up with faster way to discover antibiotics

02-Oct-2019

Russian biochemists have identified a promising new class of antibiotics. Having studied over 125,000 molecules, they found that 2-pyrazol-1-yl-thiazole derivatives exhibit antibacterial properties. One of the discovered compounds has demonstrated a good activity and low cytotoxicity, and thus ...

more

Evotec and Indivumed achieve milestone in joint strategic drug discovery collaboration

30-Sep-2019

Evotec SE and Indivumed GmbH announced that the first milestone has been successfully achieved in their joint collaboration to identify new therapeutic targets for the treatment of colorectal cancer. Under the terms of the collaboration agreement, Evotec received full access to the colorectal ...

more

image description
€7 Million to Generate First in Class Anti-TACA Antibodies for Cancer Treatment

26-Sep-2019

Tacalyx, a biotech company focused on the discovery and development of novel anti-TACA (Tumor Associated Carbohydrate Antigens) cancer therapies, announced that it has successfully secured €7 million in seed funding. The funding round involves a syndicate of leading European life science and ...

more

Evotec and Takeda enter collaboration agreement to discover clinical candidates across multiple therapeutic areas

24-Sep-2019

Evotec SE announced a strategic, multi-year drug discovery collaboration with Takeda Pharmaceutical Company Limited. Under the collaboration, the parties aim to establish at least five drug discovery programmes with the goal of Evotec delivering clinical candidates for Takeda to pursue into ...

more

New drug delivery system to enable needle-free application of drugs

Ascenion's Portfolio Company WBC Acquired by Klaria

23-Sep-2019

Ascenion GmbH, technology transfer partner of the Helmholtz Centre for Infection Research (HZI), announces the take-over of its portfolio company WBC Drug Delivery Technologies (WBC) by Klaria Pharma Holding AB in an all-stock deal. WBC was founded earlier this year to further advance a new drug ...

more

image description
Turbo-charging pharmaceutical biotechnology simulations

New simulation technology is designed to make the production of biopharmaceuticals more efficient, cost-effective and comprehensible

13-Sep-2019

Demand for biopharmaceuticals is strong: biopharmaceutical active ingredients – in other words, genetically engineered drugs – accounted for seven of the ten top-selling medications in the world in 2018. And the proportion is set to rise, as biopharmaceuticals can be used to combat conditions ...

more

Investment Plan for Europe: Successful launch of Tech Transfer Fund “KHAN-I”

13-Sep-2019

Khanu Management GmbH (Khanu), a drug discovery focused fund management team, announces the successful launch of KHAN Technology Transfer Fund I GmbH & Co KG (KHAN-I), based in Dortmund, Germany. The European Investment Fund (EIF, Luxemburg), the Austria Wirtschaftsservice GmbH (Vienna, Austria) ...

more

Page 3 From 824
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE